Le Chesnay, France

Jean-Francois Renaud De La Faverie


Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jean-Francois Renaud de la Faverie

Introduction:

Jean-Francois Renaud de la Faverie is a prolific inventor based in Le Chesnay, France, who has made significant contributions to the field of pharmaceuticals with his groundbreaking patented compounds.

Latest Patents:

With an impressive portfolio of 5 patents, Jean-Francois Renaud de la Faverie's latest inventions include new benzopyran compounds and 3-(hydroxybenzylidenyl)-indolin-2-ones. These compounds offer novel treatment options for disorders related to peroxydation processes, biosynthesis of eicosanoids, peroxidation phenomena, eicosanoid synthesis disturbances, and platelet aggregation disorders.

Career Highlights:

Jean-Francois Renaud de la Faverie is associated with the esteemed company "Adir et Compagnie," where he continues to drive innovation in the pharmaceutical industry. His relentless pursuit of scientific excellence has led to the development of pioneering medicinal products that have the potential to revolutionize healthcare practices.

Collaborations:

Throughout his career, Jean-Francois Renaud de la Faverie has collaborated closely with accomplished professionals in the field, including his esteemed coworkers Pierre Renard and Gerard Adam. These collaborations have not only enriched his own inventions but have also contributed to the advancement of pharmaceutical research as a whole.

Conclusion:

In conclusion, Jean-Francois Renaud de la Faverie stands out as a visionary inventor whose dedication to scientific innovation has resulted in a series of impactful patents that hold great promise for the future of healthcare. His transformative contributions serve as a testament to his expertise and ingenuity in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…